Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli
AIMS Microbiology · 2026 · 12 (4) · 789-814
DOI: 10.3934/microbiol.2026034 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIMS Microbiology, 2026. Verfasst von Abishek Mani und 8 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mani, A., Kalangadan, N., Magar, S., Sivaraj, B., Xavier, G. G., Diraviyam, T., Sundaresan, S., Govindarajan, S., & Rajaram, K. (2026). Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli. AIMS Microbiology, 12(4), 789-814. https://doi.org/10.3934/microbiol.2026034
Vancouver
Mani A, Kalangadan N, Magar S, Sivaraj B, Xavier GG, Diraviyam T, et al. Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli. AIMS Microbiology. 2026;12(4):789-814. doi:10.3934/microbiol.2026034
BibTeX
@article{Mani2026,
author = {Mani, Abishek and Kalangadan, Nashath and Magar, Sharayu and Sivaraj, Barath and Xavier, Gospel Gabriel and Diraviyam, Thirumalai and Sundaresan, Srivignesh and Govindarajan, Sutharsan and Rajaram, Kaushik},
title = {Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli},
journal = {AIMS Microbiology},
year = {2026},
volume = {12},
number = {4},
pages = {789--814},
doi = {10.3934/microbiol.2026034}
}
EUVIMED